AlphaYouMA
Insider selling
Maricel Apuli sold $160K of BridgeBio Pharma, Inc. (BBIO) stock
Maricel Apuli, Chief Accounting Officer of BridgeBio Pharma, Inc. (BBIO), sold 2,000 shares of BBIO stock worth $160K, per an SEC Form 4 filed Aug 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 30, 2026, 4 days before it was made public.
BBIO has moved -15.7% since the trade date, from $82.14 to $69.23 (Sep 22, 2026 close).
- Traded
- Jul 30, 2026
- Disclosed
- Aug 3, 2026
- Filing delay
- 4 days
- Price since
- -15.7%
- Role
- Chief Accounting Officer
- Source
- SEC Form 4
More BBIO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.